BioLife Solutions to use cold storage tech to store potential Covid-19 vaccine

BioLife Solutions announced Wednesday its newly acquired company, SciSafe, received a $2.7 million, two-year contract to use its cold chain management and storage tools for a potential Covid-19 vaccine. BioLife Solutions CEO Mike Rice did not name the pharmaceutical company the Bothell-based business is working with and developing a vaccine. Two U.S. companies — Massachusetts-based Moderna and New York-based Pfizer — are furthest along in development of a Covid-19 vaccine, both of which need…